Metformin in women with PCOS, Pros
- 10 June 2014
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 48 (2) , 422-426
Abstract
Metformin is an old insulin sensitizer that has been widely used in women with polycystic ovary syndrome (PCOS) to treat metabolic comorbidities and may also improve ovarian dysfunction in women with PCOS. In fact, metformin may improve insulin resistance, a common finding of PCOS, and reduce insulin blood levels. In this way, androgen production rates can be reduced, and in a subset of women, menses abnormalities and ovulatory rates may improve. The current Endocrine Society Guidelines recommend the use of metformin during adolescence, particularly when excess body weight is present. In the presence of obesity and glucose intolerance states, particularly if those patients fail to modify their lifestyles, metformin may have some significant benefits. Finally, although this drug should not be used as a first-line treatment for ovulatory dysfunctions in adult women with PCOS, there are data supporting the suggestion that in many cases pretreatment with metformin may favor ovulatory response to clomiphene citrate. This article summarizes the available evidence in the favor of metformin use in women with PCOS and emphasizes the need for an individualized therapeutic approach.Keywords
This publication has 41 references indexed in Scilit:
- Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and ImplicationsEndocrine Reviews, 2012
- Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)Clinical Endocrinology, 2008
- Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspectiveFertility and Sterility, 2008
- Consensus on infertility treatment related to polycystic ovary syndromeHuman Reproduction, 2008
- POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess SocietyThe Journal of Clinical Endocrinology & Metabolism, 2007
- The role of metformin in polycystic ovary syndrome: a systematic reviewHuman Reproduction Update, 2007
- Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeCochrane Database of Systematic Reviews, 2007
- Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndromeMetabolism, 2007
- Insulin-Lowering Agents in the Management of Polycystic Ovary SyndromeEndocrine Reviews, 2003
- Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*Endocrine Reviews, 1997